About CMC
- Manufacturing and Prototyping
- History and People
Home |
 |
 |
 |
About CMC
People and History
Edward McNamara founder, Principal
Olivia Manfrini, Nicholas J. Miele, Barry L. Sharaf, Edward McNamara, and David O. Williams. "Qualitative Results of Intracoronary Imaging During Balloon Inflation with Optical Coherence Tomography In Humans" 2003 ACC. PowerPoint download
Nicholas J. Miele, Olivia Manfrini, Barry L. Sharaf, Edward McNamara, Lynne L. Johnson, David O. Williams. Rhode Island Hospital Brown University Medical School, Providence, RI. "Quantitative and Qualitative Image Comparison Between Intravascular Ultrasound and Optical Coherence Tomography" 2003 ACC. PowerPoint download
McNamara, Solovay, Ryan "Physiological Models for Device Evaluation: An Engineer's Perspective" Handbook of Biomaterials and Applications. Marcel Dekker 1994.
Ed has over 22 years of medical experience including 13 years at CR. Bard where in worked in various divisions that include work on angioplasty balloons, wires, and stents. Ed also worked on abdominal aortic aneurysm less invasive systems and femoral closed devices. He also has extensive fiber optic experience as it retains to medical devices with Director of biomedical engineering background at Candela Laser and LightLab Imaging. Ed's engineering experience also include managing the biliary division of Bard Endoscopic where we designed, developed and manufactured the full range of produces need for biliary diagnostic and therapeutic applications. Ed has the following patents issued and publications:
Christine E. McNamara, VP of Product Development
Christine E. McNamara has served as the Vice President of Product Development at surgi-vision and oversaw thier research and development efforts and manufacturing relationships. Prior to joining us, and from October 1995 to August 1998, Ms. McNamara was a Staff Engineer at Bard Cardiology, which was purchased by Medtronic in February 1999. She is highly experienced in medical device development. Her experience encompasses catheter product design, cardiovascular research, clinical trials, regulatory implications of medical design and biotechnology initiatives. She began her career in a division of Bard Cardiology that was the first to create devices required to perform angioplasty. Working with one of the world's leading research scientists in the field of local drug delivery, she led the early development efforts in catheter development for cardiovascular applications. She later developed the prototype for the first rapid exchange coronary angioplasty catheter, which led to market acceptance of this revolutionary technology in the United States. She holds several patents, including the rapid exchange catheter patent assigned to Bard Cardiology for which she is sole inventor. Guidant, Inc., a developer of guidewires, licensed this device from Bard for fees estimated at approximately $100 million. Ms. McNamara has successfully managed projects from concept through commercialization and she holds a B.S. degree in Biomedical Engineering from Case Western Reserve University in Cleveland, Ohio, where she specialized in Biomaterials.